StemCell Institute Inc. StemCell Institute Inc.

StemCell Institute Inc.

7096

Rank in Stocks #23475
StemCell Institute Inc. provides specialized stem cell banking services... StemCell Institute Inc. provides specialized stem cell banking services throughout Japan. In addition to its core preservation activities, the company is deeply involved in the research and development of medical therapies that utilize stem cells, and it also offers banking solutions for blood vessel cells. Founded in 1999, StemCell Institute Inc. is headquartered in Tokyo, Japan, and operates as a subsidiary of Trim Medical Holdings Inc.
Share Price
$3.88
Last synced: 2026-11-20
Market Cap
$39.07M
Change (1 day)
-3.36%
Change (1 year)
-20.57%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for StemCell Institute Inc. (7096)
Operating Margin as of November 2026 TTM: 3.66%
According to StemCell Institute Inc.'s latest financial reports, its current operating margin (TTM) is 3.66%. At the end of 2025 the company had an operating margin of 15.62%.
Operating Margin history for StemCell Institute Inc. from 2020 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 3.66% -76.57%
2025 15.62% -6.35%
2024 16.68% 17.22%
2023 14.23% 11.70%
2022 12.74% 106.82%
2021 6.16% -73.04%
2020 22.85% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
33.87% -90.75%
US
-116.04% -131.70%
US
25.57% -93.01%
AU
29.35% -91.98%
NL
31.23% -91.47%
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about StemCell Institute Inc.'s operating margin

What is StemCell Institute Inc.'s operating margin?

StemCell Institute Inc.'s operating margin is 3.66%, as of Nov 2026.

What was StemCell Institute Inc.'s operating margin in 2025?

In 2025, StemCell Institute Inc.'s operating margin was 15.62%, compared with 16.68% in 2024.

How has StemCell Institute Inc.'s operating margin changed since 2020?

From 2020 to 2025, StemCell Institute Inc.'s operating margin was highest in 2020 (22.85%) and lowest in 2021 (6.16%).

How does StemCell Institute Inc.'s operating margin compare with similar companies?

StemCell Institute Inc.'s operating margin (3.66%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.